Hill Kathryn 4

What Happened

• Kathryn Hill, a director of Celanese Corporation (CE), had 1,808.351 phantom shares converted into 1,808.351 shares of common stock effective 2026-01-01. The entries show an acquisition of 1,808.351 shares at $0.00 (total $0) and a corresponding disposition of 1,808.351 derivative units (the phantom shares), reflecting the conversion from deferred-compensation units into actual shares. This is receipt of equity from a deferred compensation plan, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-01-01; Filing date: 2026-01-30 (filed late relative to the usual 2-business-day Form 4 deadline).
• Price: $0.00 per share; total reported value: $0 (reflects conversion of deferred compensation, not a cash transaction).
• Shares acquired: 1,808.351 common shares; derivative units reduced by 1,808.351.
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: F1 — each phantom share equals the right to one common share; F2 — these phantom shares were compensation deferred under the Company’s 2008 Deferred Compensation Plan and become payable in common stock per the Plan.
• Transaction code: C (conversion of derivative security).

Context

• This was a conversion of deferred-compensation phantom stock into actual shares (not an exercise for cash and not an open-market trade), so it reflects compensation vesting/payment rather than a market sentiment trade. Because the Form 4 was filed on Jan 30 for a Jan 1 transaction, the filing appears late, which is a reporting/timeliness issue but does not itself change the economic nature of the transaction.